Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Fatima, T. Schnelldorfer, J. Barton, C. Wood, H. Wiste, T. Smyrk, Lizhi Zhang, M. Sarr, D. Nagorney, M. Farnell (2010)
Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival.Archives of surgery, 145 2
A. Mathur, S. Ross, K. Luberice, Tony Kurian, M. Vice, P. Toomey, A. Rosemurgy (2014)
Margin Status Impacts Survival after Pancreaticoduodenectomy but Negative Margins Should Not be PursuedThe American Surgeon, 80
T. Pang, O. Wilson, Manuel Argueta, T. Hugh, A. Chou, J. Samra, A. Gill (2014)
Frozen section of the pancreatic neck margin in pancreatoduodenectomy for pancreatic adenocarcinoma is of limited utilityPathology, 46
Eileen OʼReilly, Anna Perelshteyn, W. Jarnagin, M. Schattner, H. Gerdes, M. Capanu, Laura Tang, J. LaValle, C. Winston, R. DeMatteo, Michael DʼAngelica, R. Kurtz, G. Abou-Alfa, D. Klimstra, M. Lowery, M. Brennan, D. Coit, D. Reidy, T. Kingham, P. Allen (2014)
A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas AdenocarcinomaAnnals of Surgery, 260
N. Lad, M. Squires, S. Maithel, Sarah Fisher, Vishes Mehta, K. Cardona, M. Russell, C. Staley, N. Adsay, D. Kooby (2013)
Is it Time to Stop Checking Frozen Section Neck Margins During Pancreaticoduodenectomy?Annals of Surgical Oncology, 20
H. Oettle, P. Neuhaus, A. Hochhaus, J. Hartmann, K. Gellert, K. Ridwelski, M. Niedergethmann, C. Zülke, J. Fahlke, M. Arning, M. Sinn, A. Hinke, H. Riess (2013)
Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.JAMA, 310 14
Mary Dillhoff, R. Yates, Kristian Wall, P. Muscarella, W. Melvin, E. Ellison, M. Bloomston (2009)
Intraoperative Assessment of Pancreatic Neck Margin at the Time of Pancreaticoduodenectomy Increases Likelihood of Margin-Negative Resection in Patients with Pancreatic CancerJournal of Gastrointestinal Surgery, 13
D. Kooby, N. Lad, M. Squires, S. Maithel, J. Sarmiento, C. Staley, N. Adsay, B. El-Rayes, S. Weber, E. Winslow, C. Cho, K. Zavala, D. Bentrem, Mark Knab, Syed Ahmad, D. Abbott, Jeffrey Sutton, Hong-Jin Kim, J. Yeh, R. Aufforth, C. Scoggins, Robert Martin, A. Parikh, Jamie Robinson, Y. Hashim, R. Fields, W. Hawkins, N. Merchant (2014)
Value of Intraoperative Neck Margin Analysis During Whipple for Pancreatic Adenocarcinoma: A Multicenter Analysis of 1399 PatientsAnnals of Surgery, 260
S. Godhi, K. Parasar, Sundeep Saluja, Pramod Mishra (2017)
Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer.Annals of Surgery
P. Nitschke, A. Volk, T. Welsch, J. Hackl, C. Reissfelder, M. Rahbari, M. Distler, H. Saeger, J. Weitz, N. Rahbari (2017)
Impact of Intraoperative Re-resection to Achieve R0 Status on Survival in Patients With Pancreatic Cancer: A Single-center Experience With 483 PatientsAnnals of Surgery, 265
Ferrone (2015)
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancerAnn Surg, 261
Annals of Surgery Volume 267, Number 3, March 2018 Letters to the Editor pancreatogastrostomy versus pancreaticojejunos- unfavorable tumor biology, which explains Traslational Medicine tomy after partial pancreatoduodenectomy. J Gas- the lack of survival advantage of reresec- Sapienza University, Rome, Italy trointest Surg. 2012;16:1686–1695. tion. In the study by Nitschke et al, several nicpetrucciani@hotmail.it 7. Duffas J-P, Suc B, Msika S, et al. A controlled significant clinicopathological differences randomized multicenter trial of pancreatogastros- tomy or pancreatojejunostomy after pancreatoduo- were demonstrated between the 3 groups Division of Digestive Surgery and denectomy. Am J Surg. 2005;189:720–729. (primary R0, secondary R0, R1), showing Liver Transplantation, Archet II Hospital 8. Topal B, Fieuws S, Aerts R, et al. Pancreaticoje- that R1 patients had more unfavorable University of Nice-Sophia-Antipolis junostomy versus pancreaticogastrostomy recon- prognostic characteristics (Ca 19–9 values, Nice, France struction after pancreaticoduodenectomy for T stage, nodal status, perineural invasion, pancreatic or periampullary tumours: a multicentre randomised trial. Lancet Oncol. 2013;14:655–662. tumor size, lymphovascular invasion). Tarek Debs, MD 9. Yeo CJ, Cameron JL, Maher MM, et al. A Primary R0 patients had the lower rate Division of Digestive Surgery and prospective randomized trial of pancreaticogas- of unfavorable features, and secondary Liver Transplantation, Archet II
Annals of Surgery – Wolters Kluwer Health
Published: Mar 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.